USRE45947EExpiredUtility
Method and compositions for increasing the anaerobic working capacity in tissues
Assignee: NATURAL ALTERNATIVES INTERNATIONAL INCPriority: Aug 12, 1996Filed: Feb 25, 2014Granted: Mar 29, 2016
Est. expiryAug 12, 2016(expired)· nominal 20-yr term from priority
A23L 1/3053A23L 1/3051A23K 1/1634A61K 35/16A61K 2300/00A61K 31/198A61K 38/05A61K 38/01A61K 31/195A61K 31/415A61K 31/197A23K 20/142A23L 33/18A23L 33/175
92
PatentIndex Score
3
Cited by
407
References
35
Claims
Abstract
A method for increasing the synthesis and accumulation of beta-alanylhistidine dipeptides, with a simultaneous increase in the accumulation of creatine, in bodily tissues of humans and animals is described. This is accomplished by causing an increase in the blood plasma concentrations of beta-alanine and creatine, or the blood plasma concentrations of beta-alanine, L-histidine and creatine, by the ingestion or infusion of a composition including beta-alanine, beta-alanine and creatine, or beta-alanine, L-histidine and creatine, or active derivatives thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A composition comprising a mixture of a creatine and a composition comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine.
2. The composition of claim 1 , further comprising an L-histidine.
3. The composition of claim 1 , wherein the beta-alanine further comprises a dipeptide, an oligopeptide, or a polypeptide.
4. The composition of claim 1 , wherein the creatine is a creatine monohydrate.
5. A dietary supplement comprising a mixture of a creatine and a composition comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine.
6. The dietary supplement of claim 5 in a unit dosage form.
7. The dietary supplement of claim 6 , wherein one dose comprises up to 99% by weight of beta-alanine.
8. The dietary supplement of claim 6 , wherein one dose comprises up to 98% by weight of L-histidine.
9. The dietary supplement of claim 5 in an injectable formulation.
10. A composition comprising a mixture of a carbohydrate and a composition comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine.
11. The composition of claim 10 , further comprising an L-histidine.
12. The composition of claim 10 , wherein the beta-alanine further comprises a dipeptide, an oligopeptide, or a polypeptide.
13. The composition of claim 10 , wherein the carbohydrate is a simple carbohydrate.
14. The composition of claim 13 , wherein the simple carbohydrate is a glucose.
15. The composition of claim 10 , further comprising creatine.
16. The composition of claim 11 , further comprising creatine.
17. A dietary supplement comprising a mixture of a carbohydrate and a composition comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine.
18. The dietary supplement of claim 17 in a unit dosage form.
19. The dietary supplement of claim 17 , wherein one dose comprises up to 99% by weight of beta-alanine.
20. The dietary supplement of claim 17 , wherein one dose comprises up to 99% by weight of a carbohydrate.
21. The dietary supplement of claim 17 in an injectable formulation.
22. A composition comprising a mixture of insulin and a composition comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine.
23. The composition of claim 22 , further comprising an L-histidine.
24. The composition of claim 22 , wherein the beta-alanine further comprises a dipeptide, an oligopeptide, or a polypeptide.
25. The composition of claim 22 , further comprising creatine.
26. The composition of claim 22 , further comprising creatine.
27. A dietary supplement comprising a mixture of insulin and a composition comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine.
28. The dietary supplement of claim 27 in a unit dosage form.
29. The dietary supplement of claim 28 , wherein one dose comprises up to 99% by weight of beta-alanine.
30. The dietary supplement of claim 28 , wherein one dose comprises up to 99% by weight of a carbohydrate.
31. The dietary supplement of claim 27 in an injectable formulation.
32. A human dietary supplement comprising beta-alanine and L-histidine.
33. A human dietary supplement comprising an amino acid or an active derivative thereof selected from the group consisting of a beta-alanine, an ester of a beta-alanine and an amide of a beta-alanine and L-histidine.
34. A human dietary supplement for increasing human muscle tissue strength comprising a mixture of creatine, a carbohydrate and free amino acid beta-alanine that is not part of a dipeptide, polypeptide or an oligopeptide, wherein the human dietary supplement does not contain a free amino acid L-histidine, wherein the free amino acid beta-alanine is in an amount that is from 0.4 g to 16.0 g per daily dose, wherein the amount increases the muscle tissue strength in the human, and wherein the human dietary supplement is formulated for one or more doses per day for at least 14 days.
35. A human dietary supplement for increasing human muscle tissue strength comprising a mixture of creatine monohydrate, a carbohydrate and free amino acid beta-alanine that is not part of a dipeptide, polypeptide or an oligopeptide, wherein the human dietary supplement does not contain a free amino acid L-histidine, wherein the free amino acid beta-alanine is in an amount that is from 0.4 g to 16.0 g per daily dose, wherein the amount increases the muscle tissue strength in the human, and wherein the human dietary supplement is formulated for one or more doses per day for at least 14 days.Join the waitlist — get patent alerts
Track USRE45947E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.